Aminoacylase 1 (ACY-1) Mediates the Proliferation and Migration of Neuroblastoma Cells in Humans Through the ERK/Transforming Growth Factor β (TGF-β) Signaling Pathways

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2021 Feb 23

PMID 33619241

Citations 3

Authors

Zimin Chen

Jiahui Gao

Jun Sun

Zhouguang Wu

Bin Wang

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Aminoacylase 1 (ACY-1) is a cytosolic enzyme that catalyzes amino acid deacylation and has been reported to participate in various human diseases. However, the role and mechanism of ACY-1 in neuroblastoma (NB) are not completely understood. The aim of this study was to elucidate the role of ACY-1 in NB. MATERIAL AND METHODS Overexpression and knockdown of ACY-1 in human NB cells were performed, and the transfection efficiency was assessed through fluorescence microscopy, real-time PCR, and western blotting. The effect of ACY-1 on tumorigenesis and metastasis was determined by cell counting, colony formation, wound healing, flow cytometry, and transwell invasion assays in vitro, and the signaling pathway was examined using western blotting. RESULTS ACY-1 overexpression inhibited proliferation and induced apoptosis in human NB cells. ACY-1 inhibited the colony formation ability, migration, and invasion of SH-SY5Y cell lines. Moreover, the ERK1/2 and TGF-ß1 signaling pathways were more active when ACY-1 was overexpressed in NB cells. However, the knockdown of ACY-1 in SH-SY5Y cell lines showed the opposite effects. CONCLUSIONS ACY-1 regulates the proliferation, migration, and invasion of human NB cells through the ERK1/2 and TGF-ß1 signaling pathways, implying that ACY-1 may serve as a therapeutic target for patients with NB.

Citing Articles

MiR-1271-5p promotes the growth and migration of neuroblastoma cells by regulating ACY-1.

Sun J, Zhang X, Chen Z, Ye X, Zhang C Transl Cancer Res. 2024; 13(7):3397-3406.

PMID: 39145058 PMC: 11319971. DOI: 10.21037/tcr-24-25.

ADGRL4 Promotes Cell Growth, Aggressiveness, EMT, and Angiogenesis in Neuroblastoma via Activation of ERK/STAT3 Pathway.

Geng G, Zhang L, Yu Y, Guo X, Li Q, Ming M Curr Mol Med. 2024; 25(1):45-55.

PMID: 38178660 DOI: 10.2174/0115665240254765231117122210.

ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway.

Shan W, Dai C, Zhang H, Han D, Yi Q, Xia B Cancers (Basel). 2022; 14(22).

PMID: 36428796 PMC: 9688869. DOI: 10.3390/cancers14225704.

ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression.

Chen H, Wang W, Xiao C, Xia D, Li F, Liu S Ann Transl Med. 2021; 9(17):1378.

PMID: 34733930 PMC: 8506526. DOI: 10.21037/atm-21-3127.

References

Wei X, Li J, Xie H, Ling Q, Wang J, Lu D . Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma. Cancer Lett. 2014; 351(1):117-25. DOI: 10.1016/j.canlet.2014.05.001. View

Johnson G, Lapadat R . Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002; 298(5600):1911-2. DOI: 10.1126/science.1072682. View

Brodeur G . Spontaneous regression of neuroblastoma. Cell Tissue Res. 2018; 372(2):277-286. PMC: 5920563. DOI: 10.1007/s00441-017-2761-2. View

Sritananuwat P, Sueangoen N, Thummarati P, Islam K, Suthiphongchai T . Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells. Cancer Cell Int. 2017; 17:85. PMC: 5615482. DOI: 10.1186/s12935-017-0454-2. View

Neilsen B, Frodyma D, McCall J, Fisher K, Lewis R . ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells. PLoS One. 2019; 14(1):e0209224. PMC: 6328106. DOI: 10.1371/journal.pone.0209224. View

Grilo A, Mantalaris A . Apoptosis: A mammalian cell bioprocessing perspective. Biotechnol Adv. 2019; 37(3):459-475. DOI: 10.1016/j.biotechadv.2019.02.012. View

Bryant K, Stalnecker C, Zeitouni D, Klomp J, Peng S, Tikunov A . Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2020; 26(6):982. DOI: 10.1038/s41591-020-0947-8. View

Miller Y, Minna J, Gazdar A . Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p. J Clin Invest. 1989; 83(6):2120-4. PMC: 303939. DOI: 10.1172/JCI114125. View

Perrier J, Giardina T, Durand A, Puigserver A . Specific enhancement of acylase I and acylpeptide hydrolase activities by the corresponding N-acetylated substrates in primary rat hepatocyte cultures. Biol Cell. 2002; 94(1):45-54. DOI: 10.1016/s0248-4900(01)01177-7. View

10.

Shohet J, Foster J . Neuroblastoma. BMJ. 2017; 357:j1863. DOI: 10.1136/bmj.j1863. View

11.

Visan I . Targeting TGF-β in cancer. Nat Immunol. 2018; 19(4):316. DOI: 10.1038/s41590-018-0076-4. View

12.

Sass J, Mohr V, Olbrich H, Engelke U, Horvath J, Fliegauf M . Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet. 2006; 78(3):401-9. PMC: 1380284. DOI: 10.1086/500563. View

13.

Iyoda T, Fukai F . Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation. Int J Cell Biol. 2012; 2012:647594. PMC: 3246736. DOI: 10.1155/2012/647594. View

14.

Coughlan D, Gianferante M, Lynch C, Stevens J, Harlan L . Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States. Pediatr Hematol Oncol. 2017; 34(5):320-330. PMC: 6764456. DOI: 10.1080/08880018.2017.1373315. View

15.

Cicenas J, Zalyte E, Rimkus A, Dapkus D, Noreika R, Urbonavicius S . JNK, p38, ERK, and SGK1 Inhibitors in Cancer. Cancers (Basel). 2017; 10(1). PMC: 5789351. DOI: 10.3390/cancers10010001. View

16.

Brown G, Hughes P, Michell R . Cell differentiation and proliferation--simultaneous but independent?. Exp Cell Res. 2003; 291(2):282-8. DOI: 10.1016/s0014-4827(03)00393-8. View

17.

Santarpia L, Lippman S, El-Naggar A . Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012; 16(1):103-19. PMC: 3457779. DOI: 10.1517/14728222.2011.645805. View

18.

Maceyka M, Nava V, Milstien S, Spiegel S . Aminoacylase 1 is a sphingosine kinase 1-interacting protein. FEBS Lett. 2004; 568(1-3):30-4. DOI: 10.1016/j.febslet.2004.04.093. View

19.

Lindner H, Lunin V, Alary A, Hecker R, Cygler M, Menard R . Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1/M20 family. J Biol Chem. 2003; 278(45):44496-504. DOI: 10.1074/jbc.M304233200. View

20.

Maik-Rachline G, Hacohen-Lev-Ran A, Seger R . Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer. Int J Mol Sci. 2019; 20(5). PMC: 6429060. DOI: 10.3390/ijms20051194. View